INTERNATIONAL PATENT: UNIVERSITE DE GENÈVE, LES HÔPITAUX UNIVERSITAIRES DE GENÈVE, CELLULA THERAPEUTICS SA, OGD2 PHARMA SAS FILES APPLICATION FOR "CHIMERIC ANTIGEN RECEPTOR TARGETING GLIOMA-ASSOCIATED ANTIGENS"

GENEVA, Dec. 15 -- UNIVERSITE DE GENÈVE (24, Rue du General Dufour1211 Geneve), LES HÔPITAUX UNIVERSITAIRES DE GENÈVE (Rue Gabrielle-Perret-Gentil 41205 Geneve), CELLULA THERAPEUTICS SA (c/o Remora Biotech, rue du Petit-Chene 121003 Lausanne), OGD2 PHARMA SAS (3 CHEMIN DU PRESSOIR CHENAIE44100 NANTES) filed a patent application (PCT/EP2025/065888) for "CHIMERIC ANTIGEN RECEPTOR TARGETING GLIOMA-ASSOCIATED ANTIGENS" on Jun 06, 2025. With publication no. WO/2025/252993, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inve...